Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic comparison and effect-to-treatment analysis

OBJECTIVE: To assess the efficacy and cost-effectiveness of modulated electrohyperthermia (mEHT) concurrent to dose-dense temozolomide (ddTMZ) 21/28 days regimen versus ddTMZ 21/28 days alone in patients with recurrent glioblastoma (GBM). DESIGN: A cohort of 54 patients with recurrent GBM treated wi...

Descripción completa

Detalles Bibliográficos
Autor principal: Roussakow, Sergey V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722101/
https://www.ncbi.nlm.nih.gov/pubmed/29102988
http://dx.doi.org/10.1136/bmjopen-2017-017387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722101/
https://www.ncbi.nlm.nih.gov/pubmed/29102988
http://dx.doi.org/10.1136/bmjopen-2017-017387

Ejemplares similares